| Literature DB >> 30748035 |
Tianyang Li1,2, Yang Yang1, Hongxiao Song1, Haijun Li1, An Cui1, Yanhou Liu1, Lishan Su1,3, Ian Nicholas Crispe1,4, Zhengkun Tu1.
Abstract
NK cells are important in regulating hepatic fibrosis via their cytotoxic killing of hepatic stellate cells (HSCs). NK cells are activated by both cytokines such as IL-12 and IL-18, and innate immune stimuli such as ligation of TLRs. The secretion of IL-18 depends upon activation of the inflammasome, whereas TLRs are stimulated by microbial products. In the case of NK cells, IL-18 acts synergistically with stimulation of TLR3 to cause cell activation and cytotoxic function. In the present study, we activated NK cells to kill HSCs via IL-18 and TLR3 ligand stimulation, and dissected the signaling pathways or molecules critical for such activation or killing. We find that such activation depends on signaling via the p38/PI3K/AKT pathway, and that the activated NK cells mediate HSC death in a TRAIL-involved mechanism. As liver fibrosis is a major global health problem with no good solution, these results emphasize that the p38/PI3K/AKT pathway in NK cells may be a novel drug target to promote fibrosis regression. ©2019 Society for Leukocyte Biology.Entities:
Keywords: IL 18; TLR3; TRAIL; p38 MAPK
Mesh:
Substances:
Year: 2019 PMID: 30748035 DOI: 10.1002/JLB.2A0118-031RR
Source DB: PubMed Journal: J Leukoc Biol ISSN: 0741-5400 Impact factor: 4.962